C. Difficile Toxin B

Three days of watery diarrhea after a course of antibiotics is the moment this test earns its keep. It answers one question fast: is a strain capable of making the toxin that injures your colon lining actually present in your gut?

What it can't answer is whether that strain is doing damage right now. The assay finds a gene, not a disease, and a large share of positive results reflect carriage rather than active infection. That gap drives everything about how to read your result.

What the Test Actually Detects

A lab takes a stool sample, hunts for one specific stretch of bacterial DNA, and copies it over and over until there's enough to see. That method is called PCR. The stretch it hunts for is tcdB, the toxin B gene, the instruction set a Clostridioides difficile bacterium uses to build one of its main injury-causing proteins.

Carrying the gene means the strain in your gut is capable of making the toxin. It doesn't mean the toxin is being made right now, or at levels high enough to injure your colon. A separate class of test, the enzyme immunoassay, measures the toxin protein itself. This one doesn't.

Why Toxin B Matters

This organism makes two large toxins, A and B. Both are enzymes that switch off the proteins holding a cell's internal scaffolding together. Cells round up, the seal between gut contents and your tissue leaks, and cells die.

Toxin B is especially potent and tightly tied to recurrent disease. Human intestinal tissue exposed to it in the lab shows surface damage, a leaky barrier, and the kind of inflammation that pulls immune cells in fast. The clinical proof came from drug development: an antibody that neutralizes toxin B reduces recurrent infection, while an antibody against toxin A alone did not add benefit. That is why antibody programs have centered on toxin B, while vaccines usually include both toxins.

Carrying It Versus Being Sick From It

This is where most positive results go wrong. In one series of patients tested with a broad molecular stool panel, only about a quarter of gene-positive samples had detectable toxin protein, and many toxin-negative patients were treated with antibiotics anyway. The gene test finds the organism whether or not it's currently causing trouble.

Sources: Guh et al. (2019); Tansarli et al. (2024); Polage et al. (2015).

Those findings pull in opposite directions, and reconciling them is the point. A gene-positive, toxin-negative result lowers the odds you have active disease, but it isn't a clean pass: one pooled analysis found that treating these patients was associated with lower all-cause mortality, and complicated disease does occasionally develop in people whose toxin test was negative. Read this as a presence test, not a good-number-bad-number test. The diagnosis lives in the combination of the gene result, the toxin result, and whether you genuinely have unformed stools.

How Early the Signal Appears Matters

The machine counts how many copying rounds it needs before the signal shows up. Fewer rounds usually means more bacterial DNA was in the sample to start with. Some labs report that count, and it can add context.

In adults with confirmed infection, earlier signals have tracked with worse outcomes. In other studies, earlier signals also made free toxin in the stool more likely. But the overlap is wide. An early signal should raise suspicion when symptoms fit; a later signal should make you ask harder whether toxin testing, inflammation, and the stool history support active disease. It should not become a home-brew cutoff.

Severity and Recurrence

Most of what's known about how sick you'll get comes from measuring the toxin protein, a different measurement than this gene test. In 615 hospitalized adults, people who ended up in intensive care, needing colon surgery, or dying had stool toxin levels tens of times higher than those who didn't, and levels were also higher in those who relapsed. The same pattern showed up in children for recurrence, where higher baseline stool toxin predicted the infection coming back.

Strain matters too. The epidemic NAP1/027 strain made roughly 23 times more toxin B than baseline strains in lab culture, and in a cohort of 1,144 patients, carrying ribotype 027 independently predicted severe illness and death. The same cohort had a useful surprise: a rapid toxin protein test did not predict those outcomes. Detecting binary toxin, a third toxin some strains carry, also flags worse disease, complications, and recurrence.

When a Result Can Mislead

• Treatment started before collection: antibiotics active against this organism can drive it below the detection limit within one to three days, so a true infection can read negative if the stool sample is collected late.
• A formed stool: most labs reject formed specimens and avoid testing people on laxatives. This test is meant for unexplained unformed stools, and running it outside that setting mostly finds carriage.
• Another cause of the diarrhea: Campylobacter, norovirus, rotavirus, or an inflammatory bowel disease flare can be the real driver while you happen to be colonized. In inflammatory bowel disease, toxin is detected less often and toxin positivity didn't track with outcomes.
• Assay limits: stool contains substances that can block PCR, and uncommon gene variants can escape the test's matching pieces. Both can produce a false negative.

What a Repeat Test Tells You, and What It Doesn't

Don't order this to confirm you're cured. The DNA lingers. In adults treated for the infection, the median time to a negative result was 9 days from starting antibiotics, about 15% were still positive at four weeks, and roughly one in eight stayed positive well beyond that despite feeling fine. Repeat testing after an initial negative within the same episode isn't supported either, since the evidence for it is too thin to recommend.

So what should you track? Your symptoms, and the labs that help define severity and risk: white blood cell count, creatinine, albumin, and stool calprotectin as a read on whether your colon is actually inflamed. Get those at the same time as a positive result and again if the picture changes. Test the gene again when unexplained watery stools return after a clear interval, not before. Lingering PCR positivity during and after treatment may itself flag a higher chance of relapse, which is one more reason a positive test weeks later shouldn't push you into another antibiotic course by itself.

What To Do With a Positive

First, find out whether your lab ran a single test or a multistep algorithm. If only the gene test was run, adding a toxin protein test on the same sample is the most useful next step, because it gives you information a gene result alone cannot. Ask whether the amplification count was reported.

Then build the clinical picture around it. A rising white count, a rising creatinine, a falling albumin, and elevated stool calprotectin alongside a positive gene and positive toxin result describe someone who needs treatment now. A positive gene test, no detectable toxin, normal inflammatory markers, and stools that aren't truly unformed lean toward carriage, and the reasonable move there is to look harder for another cause of the symptoms. Review any daily acid-blocking reflux medication with whoever prescribed it, since it raises the risk of both a first episode and a relapse. A third or later episode is the point to bring in gastroenterology or infectious disease, because that's where microbiome restoration moves from optional to central.